The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Journal club: STEP 4 and what a withdrawal design can prove — one year on

This is a generated summary. It shows the 9 most-liked posts from a topic of 63, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
OF
outline_firstTL3Wiki editor27 Oct 2024#3
t.dumitru, post #1: Journal club: STEP 4 and what a withdrawal design can prove — one year on Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 4 ( JAMA , 2021). Please read it before posting; the discussion is much better when everyone has. The question I would like us to start with is what the trial… Go to post

A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design quality is what to spend the session on.

I have kept the units in throughout, for the obvious reason.

30 likes in reply to #1 21mo
B
BirkelandTL3Regular14 Nov 2024#7
t.dumitru, post #1: Journal club: STEP 4 and what a withdrawal design can prove — one year on Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 4 ( JAMA , 2021). Please read it before posting; the discussion is much better when everyone has. The question I would like us to start with is what the trial… Go to post

Post #5 and I disagree about the size of the effect, not about the direction.

Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything that follows.

23 likes in reply to #1 20mo
T
ThibodeauTL3Regular22 Jan 2025#27

Coming back to post #25, because the follow-up matters more than the original answer.

Nobody has said the unglamorous part of STEP 4 yet, so: most of the variation is explained by things that are boring to write about and easy to check.

28 likes 18mo
CR
compounding_ruthTL4Pharmacist6 Feb 2025#32

Quietly grateful for the plain phrasing. Not every thread gets that.

21 likes 18mo
CD
c.dahlbergTL220 Feb 2025#37

My understanding of STEP 4 is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

30 likes 17mo
CR
compounding_ruthTL4Pharmacist8 Mar 2025#43

The summary that goes to the digest should say what the paper establishes, what it does not, and one thing the group could not settle. Three paragraphs, no more.

The variance between people here is larger than the effect being discussed.

21 likes 17mo
IB
i.balogunTL227 Mar 2025 · edited#50
h.nwosu, post #26: Acknowledging rather than arguing. The reasoning holds as far as I can follow it. Go to post

Two sentences on STEP 4 and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

30 likes in reply to #26 16mo
JA
j.asanteTL24 Apr 2025#53

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

26 likes 16mo
BJ
b.jansenTL227 Apr 2025#62

Post #61 is the version of this I will quote in future. One addition.

Reframing STEP 4 slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.

26 likes 15mo

Read the full topic (63 posts)

This topic was closed 180 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.
Moved from Meta-analyses by j.mwangi. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

TopicParticipantsRepliesViewsActivity
[2026 update] Journal club: FLOW and the renal composite, component by component
Journal club: FLOW and the renal composite, component by component Writing it up because I had to work it out twice and would rather nobody else did. A question about what the numbers mean rather than what…
NBTAC 2 21k 9d
Second pass at: Journal club: LEADER as the historical anchor
Posting this under the heading it deserves: Second pass at: Journal club: LEADER as the historical anchor Everything below is what sits behind that. Two things I would like separated before anyone answers on…
MGJICLAIDO+75 81 2k 2y
[2026 update] Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? — that is the question, and I have not found it answered plainly anywhere I have looked. A question about what the numbers mean rather than what…
MLSCNHHRS+105 118 18k 11mo
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field
Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that. Collecting what is known about SURMOUNT-OSA in one place,…
CIRCBPMN+47 51 617 16mo
Journal club: SUSTAIN 6 and its retinopathy signal
On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. Reading SUSTAIN 6 ( N Engl J Med , 2016) for the population rather than the effect,…
LAMRZHOJI+110 122 46k 1d

Related topics — sharing the tags number needed to treat, estimand, randomised trial

TopicParticipantsRepliesViewsActivity
A well-designed study with a badly written abstract — does this still hold?
A well-designed study with a badly written abstract — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about well-designed study on behalf…
ENCEKA 2 28k 20mo
A 40-week log with the measurement method stated — does this still hold?
A 40-week log with the measurement method stated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on 40-week log. It is…
LGDTAVGPFY+1 5 14k 2mo
SURPASS-2 and the comparator dose question that will not go away
SURPASS-2 and the comparator dose question that will not go away — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about SURPASS-2.…
EFWNFWCLJF+101 111 1.5k 18mo
Second pass at: Triple agonism: additive, synergistic, or neither?
Second pass at: Triple agonism: additive, synergistic, or neither? — that is the question, and I have not found it answered plainly anywhere I have looked. Posting a small dataset on Triple agonism. It is…
KHALBDSBBO+114 120 1.4k 10mo
Retatrutide dose escalation in the published trials
Posting this under the heading it deserves: Retatrutide dose escalation in the published trials Everything below is what sits behind that. An honest uncertainty about retatrutide dose escalation rather than a…
RMCCYMRMJW+149 159 30k 15mo